NEAT1 and Bloom syndrome: Lastly, activation of TGF‐β1 and SMAD signaling pathways by NEAT1 shRNA was inhibited when miR‐495‐3p mimics was added to HUVECs treated with BS patient serum (Figure 4E,F).